Latest filings (excl ownership)
D/A
Indefinite amount in investment fund / equity, sold $88.57 mm, 59 investors
29 Feb 24
DFAN14A
Additional proxy materials by non-management
14 Sep 23
DFAN14A
Additional proxy materials by non-management
6 Sep 23
DFAN14A
Additional proxy materials by non-management
31 Aug 23
DFAN14A
Additional proxy materials by non-management
25 Aug 23
DEFC14A
Proxy in contested solicitation
25 Aug 23
PRRN14A
Revised preliminary proxy statement filed by non-management
17 Aug 23
PREC14A
Preliminary proxy with contested solicitation
25 May 23
D/A
Indefinite amount in investment fund / equity, sold $86.77 mm, 59 investors
2 Mar 23
DFAN14A
Additional proxy materials by non-management
7 Dec 22
DFAN14A
Additional proxy materials by non-management
22 Nov 22
DEFC14A
Proxy in contested solicitation
17 Nov 22
DFAN14A
Additional proxy materials by non-management
13 Oct 22
PRRN14A
Revised preliminary proxy statement filed by non-management
12 Oct 22
CORRESP
Correspondence with SEC
12 Oct 22
DFAN14A
Additional proxy materials by non-management
29 Sep 22
PREC14A
Preliminary proxy with contested solicitation
23 Sep 22
DFAN14A
Additional proxy materials by non-management
6 Sep 22
DFAN14A
Additional proxy materials by non-management
24 Aug 22
DFAN14A
Additional proxy materials by non-management
5 Aug 22
DFAN14A
Additional proxy materials by non-management
26 Jul 22
DEFC14A
Proxy in contested solicitation
14 Jul 22
PRRN14A
Revised preliminary proxy statement filed by non-management
13 Jul 22
CORRESP
Correspondence with SEC
13 Jul 22
PREC14A
Preliminary proxy with contested solicitation
1 Jul 22
DFAN14A
Additional proxy materials by non-management
23 Jun 22
D/A
Indefinite amount in investment fund / equity, sold $76.65M, 56 investors
3 Mar 22
D/A
Indefinite amount in investment fund / equity, sold $64.06M, 48 investors
5 Mar 21
DFAN14A
Additional proxy materials by non-management
3 Mar 21
DFAN14A
Additional proxy materials by non-management
1 Mar 21
D/A
Indefinite amount in investment fund / equity, sold $54.28M, 40 investors
10 Mar 20
PRRN14A
Revised preliminary proxy statement filed by non-management
27 Aug 19
CORRESP
Correspondence with SEC
27 Aug 19
DFAN14A
Additional proxy materials by non-management
23 Aug 19
PREC14A
Preliminary proxy with contested solicitation
8 Aug 19
DFAN14A
Additional proxy materials by non-management
16 Jul 19
DFAN14A
Additional proxy materials by non-management
25 Jun 19
DFAN14A
Additional proxy materials by non-management
18 Jun 19
DFAN14A
Additional proxy materials by non-management
12 Jun 19
DEFC14A
Proxy in contested solicitation
15 May 19
Latest ownership filings
SC 13D/A
GOLD RESERVE INC
7 May 24
SC 13D/A
AmBase Corp
26 Mar 24
SC 13D/A
AmBase Corp
13 Mar 24
SC 13D/A
GOLD RESERVE INC
27 Feb 24
SC 13D/A
AmBase Corp
23 Feb 24
SC 13D/A
AmBase Corp
20 Feb 24
4
AmBase Corp
20 Feb 24
SC 13D/A
GOLD RESERVE INC
17 Jan 24
SC 13D/A
Forte Biosciences, Inc.
5 Jan 24
SC 13D/A
GOLD RESERVE INC
18 Dec 23
4
AmBase Corp
11 Oct 23
4
AmBase Corp
26 Sep 23
4
AmBase Corp
12 Sep 23
SC 13D/A
AmBase Corp
29 Aug 23
4
AmBase Corp
29 Aug 23
SC 13D
Forte Biosciences, Inc.
23 Aug 23
SC 13D/A
Forte Biosciences, Inc.
3 Aug 23
SC 13D/A
GOLD RESERVE INC
27 Jul 23
SC 13D/A
Forte Biosciences, Inc.
5 Jul 23
4
AmBase Corp
29 Jun 23
4
AmBase Corp
14 Jun 23
4
AmBase Corp
9 Jun 23
SC 13D/A
AmBase Corp
31 May 23
4
AmBase Corp
26 May 23
SC 13D/A
Forte Biosciences, Inc.
25 May 23
4
AmBase Corp
10 May 23
SC 13G/A
IMPAC MORTGAGE HOLDINGS INC
2 Mar 23
SC 13D/A
Forte Biosciences, Inc.
21 Feb 23
4
AmBase Corp
30 Jan 23
SC 13D/A
Pasithea Therapeutics Corp.
10 Jan 23
4
AmBase Corp
29 Dec 22
4
AmBase Corp
27 Dec 22
SC 13D/A
Pasithea Therapeutics Corp.
14 Dec 22
SC 13D/A
GOLD RESERVE INC
8 Nov 22
SC 13G
IMPAC MORTGAGE HOLDINGS INC
3 Nov 22
SC 13D/A
Pasithea Therapeutics Corp.
1 Nov 22
SC 13D/A
GOLD RESERVE INC
25 Oct 22
4
Eric Shahinian
30 Sep 22
SC 13D/A
Forte Biosciences, Inc.
28 Sep 22
4
Eric Shahinian
6 Sep 22